annexin v fitc propidium iodide pi dual staining kit (Keygen Biotech)
Structured Review
![BS combined with DAC showed enhanced effects in inhibiting the survival of lung cancer cells. A549 and H1299 cells were treated with BS, DAC, or BS + DAC (3:1 for A549 [BS-5 μM, DAC-1.67 μM] and 2:1 for H1299 [BS-5 μM, DAC-2.5 μM]) for 48 h, followed by <t>Annexin</t> V-PI staining. The results of total apoptosis (including both early and late apoptotic populations) are shown as mean ± SD. * P < 0.05, *** P < 0.001, **** P < 0.0001, compared with each indicated group by one-way ANOVA followed by Tukey’s post hoc test analysis ( n = 3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3144/pmc13153144/pmc13153144__41598_2026_45054_Fig4_HTML.jpg)
Annexin V Fitc Propidium Iodide Pi Dual Staining Kit, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/annexin+v+fitc+propidium+iodide+pi+dual+staining+kit/assay+kit+luciferase/pmc13153144-79-12-20
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "The combined inhibitory effect of butaselen and decitabine against lung cancer cells"
Article Title: The combined inhibitory effect of butaselen and decitabine against lung cancer cells
Journal: Scientific Reports
doi: 10.1038/s41598-026-45054-7
Figure Legend Snippet: BS combined with DAC showed enhanced effects in inhibiting the survival of lung cancer cells. A549 and H1299 cells were treated with BS, DAC, or BS + DAC (3:1 for A549 [BS-5 μM, DAC-1.67 μM] and 2:1 for H1299 [BS-5 μM, DAC-2.5 μM]) for 48 h, followed by Annexin V-PI staining. The results of total apoptosis (including both early and late apoptotic populations) are shown as mean ± SD. * P < 0.05, *** P < 0.001, **** P < 0.0001, compared with each indicated group by one-way ANOVA followed by Tukey’s post hoc test analysis ( n = 3).
Techniques Used: Staining
Related Articles
Apoptosis Assay:Article Title: The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the Article Title: The combined inhibitory effect of butaselen and decitabine against lung cancer cells. Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the Article Title: The combined inhibitory effect of butaselen and decitabine against lung cancer cells Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the Article Title: The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress. Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the Staining:Article Title: The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the Article Title: The combined inhibitory effect of butaselen and decitabine against lung cancer cells. Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the Article Title: The combined inhibitory effect of butaselen and decitabine against lung cancer cells Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the Article Title: The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress. Article Snippet: .. The cells were collected, and the apoptosis assay was conducted using the |
